Sanofi's Auvi-Q

Company: Sanofi ($SNY)
Device: Auvi-Q
Drug delivered: epinephrine

Why it's important: Sanofi makes our list with its January launch of an epinephrine pen that literally talks patients through an emergency injection. In 70% of cases that called for an epeniphrine shot, a patient's or caregiver's unease with the process led to either improper use of the needle or none at all, according to a National Institutes of Health report.

Sanofi's Auvi-Q, a prescription epinephrine injector, instructs the user via a recorded voice to hold the needle in the correct position and counts down as the injection is completed. In developing the cellphone-sized device, Sanofi took into account patients' needs and feedback to make the Auvi-Q a device worth watching.

For more:
Sanofi launches 'talking' emergency epinephrine injector
Sanofi epinephrine device guides users with voice and written instructions
EpiPen update boasts user protection

Sanofi's Auvi-Q

Suggested Articles

Genentech's Port Delivery System with ranibizumab matched Lucentis eye injections in a late-stage, wet age-related macular degeneration trial.

Honeywell aims to wean the industry of its glass habit with Aclar Edge, a new line of bottles and vials made with the company's patented plastic.

Astex's oral reformulation of a common chemo combo looks to replace lengthy infusions with a once-daily tablet that patients can take at home.